GGrantIndex
← Leaderboards

Sharon Hermes Giordano

University Of Texas Md Anderson Can Ctr

Google Scholar ↗PubMed ↗ORCID ↗
$1,487,955
Attributed
$2,261,766
Total exposure
13
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.6M · FY2005–23
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$11,973,364 · 15

By mechanism

U54$10,569,336 · 13
K07$729,363 · 1
R01$674,665 · 1

Top collaborators

Most similar at University Of Texas Md Anderson Can Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Physicians”

Research focus

PhysiciansResearch PersonnelCancer CenterUniversity Of Texas M D Anderson Cancer CenterMalignant NeoplasmsTrainingDesignAffectDiagnosisCollaborationsTranslational ResearchResearch Project GrantsCancer Health DisparityAnticancer ResearchPuerto RicoComprehensive Cancer CenterCareer DevelopmentFacultyGrantScientistHealth DisparityInstitutionPreventionSuccess

Grant awards (34)

UPR/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$1,091,199
U54 · FY2023 · CA · contact PI
UPR/MDACC: Partnership for Excellence in Cancer Research (2 of 2)$1,050,536
U54 · FY2023 · CA
Administrative Core$243,675
U54 · FY2023 · CA · contact PI
Effects of biologic and targeted therapies for rheumatoid arthritis on cancer outcomes$213,840
R01 · FY2023 · AR
UPR/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$1,091,199
U54 · FY2022 · CA
Effects of biologic and targeted therapies for rheumatoid arthritis on cancer outcomes$246,985
R01 · FY2022 · AR
Project-001$124,829
U54 · FY2022 · CA
UPR/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$1,054,072
U54 · FY2021 · CA
Effects of biologic and targeted therapies for rheumatoid arthritis on cancer outcomes$213,840
R01 · FY2021 · AR
UPR/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$77,754
U54 · FY2021 · CA
UPR/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$1,045,660
U54 · FY2020 · CA
UPR/MDACC Partnership for Excellence in Cancer Research (Luis Segarra supplement)$77,754
U54 · FY2020 · CA
UPR/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$818,406
U54 · FY2019 · CA
Community Cancer Control Outreach Core$89,234
U54 · FY2019 · CA · contact PI
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$400,000
U54 · FY2018 · CA
Admin-Core-001$160,929
U54 · FY2018 · CA
TCDC$81,962
U54 · FY2018 · CA
BEBiC$76,208
U54 · FY2018 · CA
Pilot Project D$21,390
U54 · FY2018 · CA
PEC$20,566
U54 · FY2018 · CA
Core-005$19,673
U54 · FY2018 · CA
Pilot Project F$15,288
U54 · FY2018 · CA
Core-007$3,984
U54 · FY2018 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$871,799
U54 · FY2017 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$72,364
U54 · FY2017 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$931,644
U54 · FY2016 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$72,364
U54 · FY2016 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$1,056,847
U54 · FY2015 · CA
Adherence Among Older Women with Breast Cancer$48,963
K07 · FY2009 · CA · contact PI
Adherence Among Older Women with Breast Cancer$136,080
K07 · FY2008 · CA · contact PI
Adherence Among Older Women with Breast Cancer$136,080
K07 · FY2007 · CA · contact PI
Adherence Among Older Women with Breast Cancer$136,080
K07 · FY2006 · CA · contact PI
Adherence Among Older Women with Breast Cancer$136,080
K07 · FY2005 · CA
Adherence Among Older Women with Breast Cancer$136,080
K07 · FY2004 · CA